Highlights
NASDAQ: DNLI       Denali Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
18.26   +0.08 (0.44%)  17.97 - 18.57  317,100

Overview

 
Avg Volume (4 weeks):319,285
4 Weeks Range:14.514 - 18.57
4 Weeks Price Volatility (%):
92.36%
52 Weeks Range:14.24 - 28.865
52 Weeks Price Volatility (%):
27.49%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Denali Therapeutics Inc is a biotechnology company which is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include LRRK2 Inhibitor Program which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle) and others.

  Be the first to like this.
 


 

4706  3347  638  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers